Palladone Phased Launch Should Collect One Year Of Abuse Data, Cmte. Says
Executive Summary
The first phase of launch for Purdue's Palladone (hydromorphone) should collect data on abuse and diversion for a year, FDA's Anesthetic & Life Support Advisory Committee recommended Sept. 10